Abstract
Curcumin (diferuloylmethane, 1, 6-heptadiene-3, 5-5dione-1, 7-bis (4-hydroxy-3-methoxyphenyl)), a constituent of turmeric (curcuma longa), is traditionally used in various diseases. We report the strong anti-oxidative effect of curcumin on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Results show that curcumin protects erythrocyte lipid peroxidation (MDAMalondialdehyde) and decrease of glutathione (GSH) during oxidative stress. The quotient of MDA/GSH is high during stress however presence of curcumin (10-8 M-10-5 M) decreased the index (MDA/GSH) substantiating the antioxidant effect of curcumin in a model cell system. The effect of curcumin is dose-dependent with maximum effect at 10-5M. Since oxidative stress has been implicated in the pathogenesis of many diseases/conditions, a therapeutic role of curcumin is hypothesized.
Keywords: Antioxidant, curcumin, erythrocyte, glutathione, malondialdehyde, oxidative stress, Tert-Butylhydroperoxide, lipid peroxidation, free radical
The Natural Products Journal
Title: Anti-Oxidative Effect of Curcumin Against Tert-Butylhydroperoxide Induced Oxidative Stress in Human Erythrocytes
Volume: 2 Issue: 1
Author(s): Prabhakar Singh and Syed Ibrahim Rizvi
Affiliation:
Keywords: Antioxidant, curcumin, erythrocyte, glutathione, malondialdehyde, oxidative stress, Tert-Butylhydroperoxide, lipid peroxidation, free radical
Abstract: Curcumin (diferuloylmethane, 1, 6-heptadiene-3, 5-5dione-1, 7-bis (4-hydroxy-3-methoxyphenyl)), a constituent of turmeric (curcuma longa), is traditionally used in various diseases. We report the strong anti-oxidative effect of curcumin on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Results show that curcumin protects erythrocyte lipid peroxidation (MDAMalondialdehyde) and decrease of glutathione (GSH) during oxidative stress. The quotient of MDA/GSH is high during stress however presence of curcumin (10-8 M-10-5 M) decreased the index (MDA/GSH) substantiating the antioxidant effect of curcumin in a model cell system. The effect of curcumin is dose-dependent with maximum effect at 10-5M. Since oxidative stress has been implicated in the pathogenesis of many diseases/conditions, a therapeutic role of curcumin is hypothesized.
Export Options
About this article
Cite this article as:
Singh Prabhakar and Ibrahim Rizvi Syed, Anti-Oxidative Effect of Curcumin Against Tert-Butylhydroperoxide Induced Oxidative Stress in Human Erythrocytes, The Natural Products Journal 2012; 2 (1) . https://dx.doi.org/10.2174/2210315511202010069
DOI https://dx.doi.org/10.2174/2210315511202010069 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Immunological Treatment of Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Blood-Brain Barrier Integrity and Glial Support: Mechanisms that can be Targeted for Novel Therapeutic Approaches in Stroke
Current Pharmaceutical Design Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Radiolabeled Compounds in Diagnosis of Infectious and Inflammatory Disease
Current Pharmaceutical Design Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry Use of Genetically Modified Bacteria to Modulate Adaptive Immunity
Current Gene Therapy Type 2 Diabetes Mellitus and Alzheimer’s Disease: Bridging the Pathophysiology and Management
Current Pharmaceutical Design Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Cannabinoid Signaling in Glial Cells in Health and Disease
Current Neuropharmacology IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Current Drug Targets Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Can Environmentally Relevant Levels of Aluminium Promote the Onset and Progression of Neurodegenerative Diseases?
Current Inorganic Chemistry (Discontinued) Astrocytes and Inflammasome: A Possible Crosstalk in Neurological Diseases
Current Medicinal Chemistry JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Current Medicinal Chemistry Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis
Recent Patents on CNS Drug Discovery (Discontinued) Therapeutic Targeting of Leukocyte Trafficking Across the Blood-Brain Barrier
Inflammation & Allergy - Drug Targets (Discontinued) Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry Allergen-Induced Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Indoleamine 2,3-Dioxygenase in Materno-Fetal Interaction
Current Drug Metabolism